Advertisement
Screener

BioLineRx Ltd. (BLRX) Form 6-K: Report of foreign private issuer, 2024

BioLineRx Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2024-11-25: Form 6-K; Period of report 2024-11-25; Description 6-K; Document zk2432387.htm.
  • 2024-11-21: Form 6-K; Period of report 2024-11-21; Description 6-K; Document zk2432369.htm.
  • 2024-11-12: Form 6-K; Period of report 2024-11-12; Description 6-K; Document zk2432295.htm.
  • 2024-11-05: Form 6-K; Period of report 2024-11-05; Description 6-K; Document zk2432221.htm.
FiledFormPeriod of reportDescriptionDocument
2024-11-256-K2024-11-256-Kzk2432387.htm
2024-11-216-K2024-11-216-Kzk2432369.htm
2024-11-126-K2024-11-126-Kzk2432295.htm
2024-11-056-K2024-11-056-Kzk2432221.htm
2024-10-166-K2024-10-166-Kzk2432149.htm
2024-10-016-K2024-10-016-Kzk2432094.htm
2024-08-196-K2024-08-196-Kzk2431874.htm
2024-08-156-K2024-06-306-Kzk2431827.htm
2024-06-186-K2024-06-186-Kzk2431592.htm
2024-05-306-K2024-05-306-Kzk2431529.htm
2024-05-286-K2024-05-286-Kzk2431511.htm
2024-05-246-K2024-05-246-Kzk2431506.htm
2024-05-176-K2024-05-176-Kzk2431472.htm
2024-05-066-K2024-05-066-Kzk2431388.htm
2024-04-176-K2024-04-176-Kzk2431304.htm
2024-04-106-K2024-04-106-Kzk2431273.htm
2024-04-016-K2024-04-016-Kzk2431218.htm
2024-03-266-K2024-03-266-Kzk2431198.htm
2024-03-046-K2024-03-046-Kzk2431078.htm
2024-02-286-K2024-02-286-Kzk2431057.htm
2024-02-166-K2024-02-166-Kzk2431005.htm